| 序号 |
商品名 |
申请号 |
产品号 |
申请类型 |
活性成分 |
剂型 |
规格 |
参比药物 |
参比标准 |
申请号批准日期 |
产品号批准日期 |
申请人 |
市场状态 |
| 1 |
HYDROCHLOROTHIAZIDE |
218248 |
1 |
ANDA |
HYDROCHLOROTHIAZIDE |
SOLUTION;ORAL |
50MG/5ML |
No |
Yes |
2026-10-07 |
2026-10-07 |
RUBICON RESEARCH |
Prescription |
| 2 |
MIRABEGRON |
219599 |
1 |
ANDA |
MIRABEGRON |
TABLET, EXTENDED RELEASE;ORAL |
25MG |
No |
No |
2026-10-07 |
2026-10-07 |
CREEKWOOD PHARMS |
Prescription |
| 3 |
MIRABEGRON |
219599 |
2 |
ANDA |
MIRABEGRON |
TABLET, EXTENDED RELEASE;ORAL |
50MG |
No |
No |
2026-10-07 |
2026-10-07 |
CREEKWOOD PHARMS |
Prescription |
| 4 |
FIDAXOMICIN |
219737 |
1 |
ANDA |
FIDAXOMICIN |
TABLET;ORAL |
200MG |
No |
No |
2026-10-07 |
2026-10-07 |
HIKMA |
Prescription |
| 5 |
SUGAMMADEX SODIUM |
215701 |
1 |
ANDA |
SUGAMMADEX SODIUM |
SOLUTION;INTRAVENOUS |
EQ 200MG BASE/2ML (EQ 100MG BASE/ML) |
No |
No |
2026-10-06 |
2026-10-06 |
SHANDONG |
Prescription |
| 6 |
SUGAMMADEX SODIUM |
215701 |
2 |
ANDA |
SUGAMMADEX SODIUM |
SOLUTION;INTRAVENOUS |
EQ 500MG BASE/5ML (EQ 100MG BASE/ML) |
No |
No |
2026-10-06 |
2026-10-06 |
SHANDONG |
Prescription |
| 7 |
SOLRIAMFETOL HYDROCHLORIDE |
218725 |
1 |
ANDA |
SOLRIAMFETOL HYDROCHLORIDE |
TABLET;ORAL |
EQ 75MG BASE |
No |
No |
2026-10-06 |
2026-10-06 |
AUROBINDO PHARMA LTD |
Prescription |
| 8 |
SOLRIAMFETOL HYDROCHLORIDE |
218725 |
2 |
ANDA |
SOLRIAMFETOL HYDROCHLORIDE |
TABLET;ORAL |
EQ 150MG BASE |
No |
No |
2026-10-06 |
2026-10-06 |
AUROBINDO PHARMA LTD |
Prescription |
| 9 |
DESFLURANE |
90363 |
1 |
ANDA |
DESFLURANE |
LIQUID;INHALATION |
1 |
No |
No |
2026-10-05 |
2026-10-05 |
PIRAMAL CRITICAL |
Prescription |
| 10 |
PERAMPANEL |
220492 |
1 |
ANDA |
PERAMPANEL |
TABLET;ORAL |
2MG |
No |
No |
2026-10-02 |
2026-10-02 |
AUROBINDO PHARMA LTD |
Prescription |